These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36524950)

  • 1. Perceptions of Invasiveness: A Moving Target for Neuromodulation.
    Lipsman N; McDonald PJ; Illes J
    AJOB Neurosci; 2023; 14(1):15-17. PubMed ID: 36524950
    [No Abstract]   [Full Text] [Related]  

  • 2. The Utility of Diffusion Tensor Imaging in Neuromodulation: Moving Beyond Conventional Magnetic Resonance Imaging.
    Tohyama S; Walker MR; Sammartino F; Krishna V; Hodaie M
    Neuromodulation; 2020 Jun; 23(4):427-435. PubMed ID: 32045071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving Beyond a Pain Intensity Reporting: The Value of Goal Identification in Neuromodulation.
    Goudman L; Moens M
    Neuromodulation; 2020 Oct; 23(7):1057-1058. PubMed ID: 32270533
    [No Abstract]   [Full Text] [Related]  

  • 4. Unique Characteristics of the Dorsal Root Ganglion as a Target for Neuromodulation.
    Esposito MF; Malayil R; Hanes M; Deer T
    Pain Med; 2019 Jun; 20(Suppl 1):S23-S30. PubMed ID: 31152179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neuromodulation call to arms.
    Hagedorn JM
    Reg Anesth Pain Med; 2019 Apr; 44(4):532. PubMed ID: 30914476
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuromodulation in the management of neurogenic lower urinary tract dysfunction].
    Keppene V; Mozer P; Chartier-Kastler E; Ruffion A
    Prog Urol; 2007 May; 17(3):609-15. PubMed ID: 17622098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric gastrointestinal neuromodulation: A review.
    El-Chammas KI; Santucci NR; Mansi S; Kaul A
    Saudi J Gastroenterol; 2022; 28(6):403-412. PubMed ID: 35418002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on the current developments with neuromodulation for the treatment of epilepsy.
    Kwon CS; Jetté N; Ghatan S
    Expert Rev Neurother; 2020 Feb; 20(2):189-194. PubMed ID: 31815564
    [No Abstract]   [Full Text] [Related]  

  • 9. The Evolution of Neuromodulation in the Treatment of Chronic Pain: Forward-Looking Perspectives.
    Fishman MA; Antony A; Esposito M; Deer T; Levy R
    Pain Med; 2019 Jun; 20(Suppl 1):S58-S68. PubMed ID: 31152176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromodulation techniques: a comparison of available and new therapies.
    Vasavada SP; Goldman HB; Rackley RR
    Curr Urol Rep; 2007 Nov; 8(6):455-60. PubMed ID: 18042324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacral neuromodulation for treatment of lower urinary tract dysfunction.
    Hohenfellner M; Dahms SE; Matzel K; Thüroff JW
    BJU Int; 2000 May; 85 Suppl 3():10-9; discussion 22-3. PubMed ID: 11954192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current use of neuromodulation for bladder dysfunction.
    Sherman ND; Amundsen CL
    Minerva Ginecol; 2006 Aug; 58(4):283-93. PubMed ID: 16957672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existing and emerging applications for the neuromodulation of nerve activity through targeted delivery of electric stimuli.
    Ginn C; Patel B; Walker R
    Int J Neurosci; 2019 Oct; 129(10):1013-1023. PubMed ID: 31092102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Approaches to Neuromodulation in Primary Headaches: Focus on Vagal Nerve and Sphenopalatine Ganglion Stimulation.
    Puledda F; Goadsby PJ
    Curr Pain Headache Rep; 2016 Jul; 20(7):47. PubMed ID: 27278441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromodulation for the Treatment of Lower Urinary Tract Symptoms.
    Yamanishi T; Kaga K; Fuse M; Shibata C; Uchiyama T
    Low Urin Tract Symptoms; 2015 Sep; 7(3):121-32. PubMed ID: 26663726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting.
    Brunoni AR; Teng CT; Correa C; Imamura M; Brasil-Neto JP; Boechat R; Rosa M; Caramelli P; Cohen R; Del Porto JA; Boggio PS; Fregni F
    Arq Neuropsiquiatr; 2010 Jun; 68(3):433-51. PubMed ID: 20602051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromodulation versus medication for overactive bladder: the case for early intervention.
    Burks FN; Peters KM
    Curr Urol Rep; 2009 Sep; 10(5):342-6. PubMed ID: 19709480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of Electrical Neuromodulation for Inflammatory Bowel Disease.
    Cheng J; Shen H; Chowdhury R; Abdi T; Selaru F; Chen JDZ
    Inflamm Bowel Dis; 2020 Jul; 26(8):1119-1130. PubMed ID: 31782957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for anesthetic management for intraoperative neuromodulation cases.
    Zhu AC; Tram J; Waterman R; Wallace M; Chakravarthy K
    Pain Manag; 2022 May; 12(4):557-567. PubMed ID: 34886683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
    Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
    J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.